CeNeRx BioPharma's Debt - III Round

CeNeRx BioPharma raised a round of funding on June 15, 2012.

CeNeRx is a specialty biopharmaceutical company developing and commercializing treatments for diseases of the central nervous system (CNS). CeNeRx is developing a balanced portfolio that includes clin…

Articles about CeNeRx BioPharma's Debt - III Round: